Meloxicam in Combination with Mitoxantrone or Vinblastine as First-Line Treatment for Non-Resectable Urothelial Cell Carcinoma in Dogs

Meloxicam in Combination with Mitoxantrone or Vinblastine as First-Line Treatment for Non-Resectable Urothelial Cell Carcinoma in Dogs

Cyclooxygenase (COX) inhibitors have been demonstrated to have antitumour activity in canine urothelial cell carcinoma (UCC), given as a sole treatment or in combination with chemotherapy. The purpose of this retrospective multi-institutional study was to assess the efficacy of meloxicam in combinat...

Full description

Bibliographic Details
Main Authors: Estel.la Ciriano Cerdà, Alenka Lavra Zajc, Riccardo Finotello, Kirsty Macdonald, Filipa Lyseight, Nele Van Den Steen, Katia Sanchez Gonzalez, Mary Marrington, Jessica Grant
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Veterinary Sciences
Subjects:
bladder cancer
canine
chemotherapy
COX inhibitor
oncology
Online Access:https://www.mdpi.com/2306-7381/10/8/529

Internet

https://www.mdpi.com/2306-7381/10/8/529

Similar Items